Publications by authors named "L Reys"
In Reply: Risks for Oculomotor Nerve Palsy and Time to Recovery After Surgical Clipping of Posterior Communicating Artery Aneurysms: A Multicenter Retrospective Cohort Study.
Marcos Devanir Silva da Costa Joao Vitor Fernades Lima Marco Antonio Zanini Pedro Tadao Hamamoto Filho Rodrigo Ferrari Fernandes Naufal Lorena Reys
Neurosurgery
January 2024
Current management for diabetes has stimulated the development of versatile 3D-based hydrogels as in vitro platforms for insulin release and as support for the encapsulation of pancreatic cells and islets of Langerhans. This work aimed to create agarose/fucoidan hydrogels to encapsulate pancreatic cells as a potential biomaterial for diabetes therapeutics. The hydrogels were produced by combining fucoidan (Fu) and agarose (Aga), marine polysaccharides derived from the cell wall of brown and red seaweeds, respectively, and a thermal gelation process.
View Article and Find Full Text PDFRisks for Oculomotor Nerve Palsy and Time to Recovery After Surgical Clipping of Posterior Communicating Artery Aneurysms: A Multicenter Retrospective Cohort Study.
Marcos Devanir Silva da Costa Joao Vitor Fernades Lima Marco Antonio Zanini Pedro Tadao Hatamoto Filho Rodrigo Ferrari Fernandes Naufal Lorena Reys
Neurosurgery
June 2023
Article Synopsis
- * Researchers analyzed data from over 500 patients across multiple neurosurgery centers to identify risk factors for ONP, finding that larger aneurysms (≥7.5 mm) and smoking significantly increased the likelihood of developing ONP.
- * Results indicated that 80.7% of patients experienced some improvement in ONP after surgical treatment, with a median recovery time of 90 days, suggesting positive outcomes for those treated.
Fucoidan-based hydrogels particles as versatile carriers for diabetes treatment strategies.
J Biomater Sci Polym Ed
October 2022
Article Synopsis
- There is a need for better diabetes therapies due to the inefficiency of current treatments, which struggle to manage blood glucose levels effectively.
- This research explores the use of fucoidan, a marine polysaccharide, to create drug carriers that can help deliver insulin and maintain the health of insulin-producing cells.
- The study shows that methacrylated fucoidan can release insulin in a controlled manner and support the growth of pancreatic beta cells, suggesting its potential as a promising treatment option for diabetes.